Oncogenic miR-223 has been found to diminish DNA repair and apoptosis potentials of esophageal cancer cells and increase the resistance to DDP via targeting and down-regulating Poly (ADP-ribose) polymerase 1 (PARP1) (Streppel et al., 2013). This evidence concerns the gene PARP1 and esophageal cancer.